Clinical Trials in Salt Lake City

Showing 15361-15380 of 16,694 trials

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

NCT00003223

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of fenretinide may be an effective way to prevent the development of cancer in patients with neoplasia of the mouth. PURPOSE: Phase II trial to study the effectiveness of fenretinide in preventing cancer in patients who have neoplasia of the mouth.

Head and Neck Cancer

SWOG Cancer Research Network5 participantsStarted Dec 1997

Tucson, Arizona, United States • Tucson, Arizona, United States • Kansas City, Kansas, United States +12 more locations

COMPLETEDPhase 3< 1 mile

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

NCT00471146

The purpose of this study is to determine whether investigational study drug, AG-013736, and gemcitabine are effective in the first-line treatment of advanced pancreatic cancer.

Carcinoma, Pancreatic Ductal

Pfizer630 participantsStarted Jul 2007

Antioch, California, United States • Corona, California, United States • Glendora, California, United States +201 more locations

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Find Trials by Condition in Salt Lake City

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

CRESTOR Athero Imaging Head to Head IVUS Study

A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep

Ulimorelin Study of Efficacy and Safety (ULISES 007)

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

Comparison Study for Safety and Efficacy of Two Devices for the Treatment of the Great Saphenous Vein

Ulimorelin Study of Efficacy and Safety (ULISES 008)

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure

Calfactant for Direct Acute Respiratory Distress Syndrome

Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors